Nalo Therapeutics is a biotech company that develops pharmaceutical products intended to treat hematological and solid tumors. Its products are small molecule-based medicines for the treatment of cancer, enabling customers to purchase medicines to treat cancer cells that originate from uncontrolled cellular growth. The company was founded in 2017 and is based in New Castle, Delaware.